THE SCIENCE OF OPTIMAL AGING Trademark

Trademark Overview

On Sunday, February 27, 2005, a trademark application was filed for THE SCIENCE OF OPTIMAL AGING with the United States Patent and Trademark Office. The USPTO has given the THE SCIENCE OF OPTIMAL AGING trademark a serial number of 78575907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2009. This trademark is owned by Elixir Pharmaceuticals, Inc.. The THE SCIENCE OF OPTIMAL AGING trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for use in the prevention and treatment of age-related genetic and metabolic medical conditions; pharmaceutical products for use in the prevention and treatment of diabetes and obesity
the science of optimal aging

General Information

Serial Number78575907
Word MarkTHE SCIENCE OF OPTIMAL AGING
Filing DateSunday, February 27, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2005

Trademark Statements

Goods and ServicesPharmaceutical products for use in the prevention and treatment of age-related genetic and metabolic medical conditions; pharmaceutical products for use in the prevention and treatment of diabetes and obesity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 5, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElixir Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameElixir Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 16, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 16, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 12, 2008EXTENSION 5 GRANTED
Tuesday, August 12, 2008EXTENSION 5 FILED
Tuesday, August 12, 2008TEAS EXTENSION RECEIVED
Monday, February 4, 2008EXTENSION 4 GRANTED
Monday, February 4, 2008EXTENSION 4 FILED
Monday, February 4, 2008TEAS EXTENSION RECEIVED
Wednesday, August 8, 2007EXTENSION 3 GRANTED
Wednesday, August 8, 2007EXTENSION 3 FILED
Wednesday, August 8, 2007TEAS EXTENSION RECEIVED
Thursday, February 8, 2007EXTENSION 2 GRANTED
Thursday, February 8, 2007EXTENSION 2 FILED
Thursday, February 8, 2007TEAS EXTENSION RECEIVED
Monday, October 30, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 30, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 1, 2006EXTENSION 1 GRANTED
Tuesday, August 1, 2006EXTENSION 1 FILED
Tuesday, August 1, 2006TEAS EXTENSION RECEIVED
Wednesday, July 5, 2006ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 14, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2005PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2005NOTICE OF PUBLICATION
Thursday, September 29, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 23, 2005ASSIGNED TO LIE
Thursday, September 22, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 22, 2005EXAMINERS AMENDMENT E-MAILED
Thursday, September 22, 2005EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 21, 2005ASSIGNED TO EXAMINER
Monday, June 13, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, March 5, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

aging optimal science pharmaceutical prevention treatment products diabetes obesity conditions genetic related metabolic